Publicaciones (208) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. Anticipating the side effects of benznidazole: HLA-B*35 and patch test

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 8, pp. 430-434

  2. Concomitant Serological and Molecular Methods for Strongyloides stercoralis Screening in an Endemic Area of Spain

    Tropical Medicine and Infectious Disease, Vol. 9, Núm. 9

  3. Cutibacterium Species Valvular and Cardiac Device-Related Infective Endocarditis: Contemporary Data from the GAMES Prospective Cohort (2008-2023)

    Clinical Infectious Diseases, Vol. 79, Núm. 3, pp. 663-671

  4. Pseudoaneurysm as an unusual complication in bone lengthening

    JPRAS Open, Vol. 41, pp. 98-103

  5. Technique “without bone tunnels” (Micheli–Kocher) in anterior cruciate ligament reconstruction in growing patients. Surgical details and our experience with 19 cases

    Revista Espanola de Cirugia Ortopedica y Traumatologia

  6. Treatment of Schatzker Type VI Tibia Fractures Using Circular External Fixation: State of the Art, Surgical Technique and Results

    Journal of Clinical Medicine, Vol. 13, Núm. 5

2023

  1. Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years

    GeroScience, Vol. 45, Núm. 1, pp. 543-553

  2. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  3. EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci

    International Journal of Antimicrobial Agents, Vol. 62, Núm. 3

  4. Early Identification and Treatment of Trochlear Knee Dysplasia

    Journal of Personalized Medicine, Vol. 13, Núm. 5

  5. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 7, pp. 1658-1666

  6. Executive summary consensus statement of imported diseases group (GEPI) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Society of Tropical Medicine and International Health (SETMSI), on the diagnostic and treatment of imported schistosomiasis

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 8, pp. 505-512

  7. Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; the HOPE-Covid-19 Registry

    Anti-Infective Agents, Vol. 21, Núm. 2, pp. 66-78

  8. Implementation and evaluation of visitation procedures for patients hospitalised with COVID-19

    British Journal of Health Care Management, Vol. 29, Núm. 12

  9. Incidence and predictors of sternal surgical wound infection in cardiac surgery: A prospective study

    International Wound Journal, Vol. 20, Núm. 4, pp. 917-924

  10. Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole

    Revista da Sociedade Brasileira de Medicina Tropical, Vol. 56

2022

  1. Bartonella Endocarditis in Spain: Case Reports of 21 Cases

    Pathogens, Vol. 11, Núm. 5

  2. CA 15-3 prognostic biomarker in SARS-CoV-2 pneumonia

    Scientific Reports, Vol. 12, Núm. 1

  3. Confirmation of SARS-CoV-2 airborne dissemination indoors using “COVID-19 traps”

    Journal of Infection, Vol. 84, Núm. 3, pp. 343-350

  4. Consensus document for the management of schistosomiasis in Primary Care

    Atencion Primaria, Vol. 54, Núm. 8